title: Phase II trial of the histone deacetylase inhibitor belinostat in women with platinum resistant epithelial ovarian cancer and micropapillary (LMP) ovarian tumours.
authors.affiliation: Princess Margaret Phase II Consortium, Toronto, Canada. helen.mackay@uhn.on.ca
authors.forename: Helen J
authors.initials: HJ
authors.lastname: Mackay
authors.forename: Hal
authors.initials: H
authors.lastname: Hirte
authors.forename: Terrence
authors.initials: T
authors.lastname: Colgan
authors.forename: Al
authors.initials: A
authors.lastname: Covens
authors.forename: Katrina
authors.initials: K
authors.lastname: MacAlpine
authors.forename: Pamela
authors.initials: P
authors.lastname: Grenci
authors.forename: Lisa
authors.initials: L
authors.lastname: Wang
authors.forename: Jaqueline
authors.initials: J
authors.lastname: Mason
authors.forename: Pnu-An
authors.initials: PA
authors.lastname: Pham
authors.forename: Ming-S
authors.initials: MS
authors.lastname: Tsao
authors.forename: James
authors.initials: J
authors.lastname: Pan
authors.forename: James
authors.initials: J
authors.lastname: Zwiebel
authors.forename: Amit M
authors.initials: AM
authors.lastname: Oza
mesh_terms: D000107:Acetylation / Q000187:drug effects; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000970:Antineoplastic Agents / Q000008:administration & dosage* / Q000009:adverse effects; D002291:Carcinoma, Papillary / Q000188:drug therapy*; D019008:Drug Resistance, Neoplasm; D005260:Female; D056572:Histone Deacetylase Inhibitors / Q000008:administration & dosage* / Q000009:adverse effects; D006657:Histones / Q000378:metabolism; D006801:Humans; D006877:Hydroxamic Acids / Q000008:administration & dosage* / Q000009:adverse effects; D007262:Infusions, Intravenous; D008875:Middle Aged; D009364:Neoplasm Recurrence, Local / Q000188:drug therapy*; D010051:Ovarian Neoplasms / Q000188:drug therapy*; D013449:Sulfonamides; D016896:Treatment Outcome
chemical_list: D000970:Antineoplastic Agents; D056572:Histone Deacetylase Inhibitors; D006657:Histones; D006877:Hydroxamic Acids; D013449:Sulfonamides; C487081:belinostat